Navigation Links
Transdel Pharmaceuticals Announces Management Reorganization
Date:2/18/2010

from the Phase 3 clinical trial may vary from the Company's initial conclusions; the FDA may not agree with the Company's interpretation of such results or may challenge the adequacy of the Company's clinical trial design or the execution of the clinical trial; the FDA may continue to require the Company to complete additional clinical trials for Ketotransdel® before the Company can submit a 505(b)2 NDA application; the results of any future clinical trials may not be favorable and the Company may never receive regulatory approval for Ketotransdel®; and the Company's current need to raise additional funding to complete its product development plans. More detailed information about the Company and the risk factors that may affect the realization of forward-looking statements is set forth in the Company's filings with the Securities and Exchange Commission, including its Annual Report on Form 10-K and its Quarterly Reports on Form 10-Q filed with the SEC. Such documents may be read free of charge on the SEC's web site at www.sec.gov. You are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date hereof. All forward-looking statements are qualified in their entirety by this cautionary statement and the Company undertakes no obligation to revise or update this press release to reflect events or circumstances after the date hereof. This caution is made under the safe harbor provisions of Section 21E of the Private Securities Litigation Reform Act of 1995.

SOURCE Transdel Pharmaceuticals, Inc.

RELATED LINKS
http://www.transdelpharma.com

'/>"/>

SOURCE Transdel Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Transdel Pharmaceuticals to Webcast Presentation at 4th Annual BIOCOM Investor Conference
2. Transdel Enrolls First Patient for Ketotransdel(TM) Phase 3 Clinical Trial
3. Transdel Initiates Ketotransdel(TM) Phase 3 Clinical Program for Pain
4. Transdel Pharmaceuticals Advances Lead Topical Pain Drug into Phase 3 Program
5. Merz Pharmaceuticals Introduces New Mederma(R) Stretch Marks Therapy Now Available in Drugstores Nationwide
6. GlaxoSmithKline President of North America Pharmaceuticals, Deirdre Connelly, Named 2010 Woman of the Year by the Healthcare Businesswomens Association
7. Oramed Pharmaceuticals Expands Scientific Advisory Board With the Appointment of John Amatruda, M.D.
8. Alexza Pharmaceuticals to Host 2010 Investor/Analyst Day on Thursday, February 18, 2010
9. Endo Pharmaceuticals to Announce Fourth Quarter and Full Year 2009 Financial Results on February 22, 2010
10. Amira Pharmaceuticals Announces Efficacy of LPA1 Antagonist in a Preclinical Model of Scleroderma
11. ISTA Pharmaceuticals Announces 2010 Financial Guidance
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2014)... 24, 2014  Arena Pharmaceuticals, Inc. (NASDAQ: ARNA ... corporate overview and update at the Piper Jaffray 26 th ... 8:30 a.m. Eastern Time (5:30 a.m. Pacific Time), at The ... . A live audio webcast of the presentation ... website at www.arenapharm.com . A replay of the presentation ...
(Date:11/24/2014)... - Milestone Pharmaceuticals, Inc. today announced data from a Phase ... Australia of MSP-2017, a novel calcium ... supraventricular tachycardia (PSVT).  The results demonstrated that an ... single doses up to and including 140 mg ... including rapid onset, and validating proof of concept ...
(Date:11/24/2014)... RATON, Fla. , Nov. 24, 2014  Marta Rendon, ... Medicine, Boca Raton , FL and international key ... physicians selected from the United States ... in Istanbul, Turkey . Here, at this ... meet West, as world renowned facial plastic surgery experts from ...
Breaking Medicine Technology:Arena Pharmaceuticals to Present at Piper Jaffray 26th Annual Healthcare Conference 2Arena Pharmaceuticals to Present at Piper Jaffray 26th Annual Healthcare Conference 3Milestone Announces Positive Phase 1 Data for MSP-2017; Supports Advancement into Phase 2 in PSVT Patients 2Milestone Announces Positive Phase 1 Data for MSP-2017; Supports Advancement into Phase 2 in PSVT Patients 3Marta Rendon, MD Selected To Attend Prestigious, Global Aesthetic Experts Summit! 2Marta Rendon, MD Selected To Attend Prestigious, Global Aesthetic Experts Summit! 3
... /PRNewswire-Asia-FirstCall/ -- BMP Sunstone Corporation (Nasdaq: BJGP ... the Company plans to release third quarter 2010 financial ... closes. The Company will hold a conference ... to discuss its results.  Listeners may access the call ...
... Pharmaceuticals, Inc. (Nasdaq: REGN ) will webcast ... Conference on Wednesday, November 10, 2010.  The presentation is ... Time).  The session may be accessed through the Company,s ... page.  An archived version of the presentation will be ...
Cached Medicine Technology:BMP Sunstone to Report Third Quarter 2010 Financial Results 2
(Date:11/24/2014)... (PRWEB) November 24, 2014 Global ... 6.19 billion by 2020, according to a new ... rates of cardiac arrhythmias clubbed with growing global ... this market. Though still in the budding stage, ... rise in usage rates in the recent times, ...
(Date:11/24/2014)... Residents of retirement communities in Ohio and Virginia ... TALENT, an annual online talent competition and showcase organized ... crooners, to seniors partying on a “night on the ... young. , “SENIORS GOT TALENT, while still having a ... always been about highlighting the vibrancy of being a ...
(Date:11/24/2014)... Westbury, New York (PRWEB) November 24, 2014 ... recently contacted by the Family and Children's Association ... products such as soap, shampoo, mouthwash and other such ... senior citizens who are home bound, living in nursing ... are intended to greatly enhance the well being of ...
(Date:11/24/2014)... CA (PRWEB) November 24, 2014 SafeHandles™ ... episode of Innovations with Ed Begley Jr, airing via ... was created to provide a passive, non-invasive, replaceable, and ... how SafeHandles™ incorporates custom-fit shrinkable sleeves and adhesives to ... , “At the core of SafeHandles is the ...
(Date:11/24/2014)... 2014 "My friend was killed when ... cross the street in his motorized wheelchair," said an ... I came up with this idea so that people ... He developed the Safety Lites to make a wheelchair ... The device ensures that motorists can see the wheelchair. ...
Breaking Medicine News(10 mins):Health News:Electrophysiology Devices Market Worth Forecasted To Reach $6.19 Billion By 2020: Grand View Research, Inc. 2Health News:Electrophysiology Devices Market Worth Forecasted To Reach $6.19 Billion By 2020: Grand View Research, Inc. 3Health News:Electrophysiology Devices Market Worth Forecasted To Reach $6.19 Billion By 2020: Grand View Research, Inc. 4Health News:Nursing Homes & Assisted Living Retirement Communities Enter Seniors Guide's Seniors Got Talent 2Health News:Nursing Homes & Assisted Living Retirement Communities Enter Seniors Guide's Seniors Got Talent 3Health News:The Holiday Inn Westbury - Long Island gives back to the local Long Island community, and also goes beyond borders to assist those in need during the 2014 Holiday Season 2Health News:The Holiday Inn Westbury - Long Island gives back to the local Long Island community, and also goes beyond borders to assist those in need during the 2014 Holiday Season 3Health News:New Episode of Innovations TV Series to Feature SafeHandles™ 2
... Breakfast alone may not be the solution to reducing ... selections// could prove beneficial in the battle against the ... ,Published monthly by the Institute of Food ... nutrition and metabolic research and translates it into food ...
... HIV-infected child, who was allegedly refused treatment by doctors ... US-based Indian crusader against medical negligence to support him., ... and a poor labourer, approached the People for Better ... after government hospitals allegedly refused to perform a surgery ...
... mechanism that anthrax bacteria use to elude the body’s ... to lessen the effect of anthrax bacterial species Bacillus ... ,For the last four years, Dr. Rowe Byers, professor ... microbiology, have worked on the project that led to ...
... caffeine content on cans and bottles of its flagship soda ... substance. ,The new labels, which coincide with the ... separately state "caffeine content: 25mg/8fl oz". ,The disclosure, ... comes as consumer and health groups increasingly petition for the ...
... has been dubbed 'Dr. No' for her stance against AIDS// ... , The minister had earned the ... to South Africa’s escalating AIDS problems. ,She ... combating AIDS, over antiretroviral drugs used all over the world. ...
... The Federation of American Hospitals has urged the cause ... insurance, underlining// the imperativeness of basic health coverage. ... might instigate a federal legislation mandating employees to avail ... or buy it of their own accord or accept ...
Cached Medicine News:Health News:NRI Fights for HIV Child Who was Refused Treatment 2Health News:Discovery Leads to Way to Curb Anthrax Effect 2Health News:Pepsi to Put Caffeine Content on Labels 2Health News:Dr. ‘NO’ Admitted for Lung Conditi 2
The Bledsoe Achilles Boot saves time by eliminating casting series required to stretch the achilles tendon during rehab....
Get back into action with MalleoLoc. Perfect for playing basketball, volleyball or everyday activities. The MalleoLoc stabilizing ankle brace increases ankle stability without restricting mobility....
DarcoGel™ Upper chamber is foam filled, conforms to calf; gel-filled lower chamber molds to the malleoli for a custom fit. Freeze the removable liner for cold therapy. One size. Fits left or ri...
Softsplint after bunion surgery. Hook-and-loop closure. Maintains hallux positioning and metatarsophalangeal alignment. Washable....
Medicine Products: